Position in ADCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$262,676
+$97,649 QoQ
Shares Held
70,047
+49.8% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $1,875,467,383 across 39 Drug Manufacturers - Specialty & Generic names. ADCT ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
65,864,104 | $889,824,044 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
405,447 | $240,421,961 | |
| 3 | ALKS |
Alkermes plc.
|
4,664,576 | $164,939,406 | |
| 4 | PRGO |
PERRIGO Co plc
|
13,376,776 | $143,666,573 | |
| 5 | ZTS |
Zoetis Inc.
|
1,018,088 | $120,348,181 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
3,201,490 | $76,611,655 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
919,732 | $69,761,671 | |
| 8 | LQDA |
Liquidia Corp
|
953,151 | $35,971,917 |
All Filings in ADCT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $262,676 | 70,047 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $165,027 | 46,750 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $148,852 | 37,213 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $99,730 | 37,213 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $51,057 | 36,211 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $57,373 | 28,831 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $90,817 | 28,831 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $71,024 | 22,476 | Shares | Defined | 2024-08-14 | |
| 2023-06-30 | $2,626,951 | 1,221,838 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,547,554 | 1,306,438 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,711,251 | 1,487,305 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,739,434 | 1,190,754 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,591,619 | 1,961,210 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $36,176,122 | 2,462,636 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $57,599,027 | 2,851,437 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $76,828,578 | 2,828,740 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $64,833,944 | 2,662,585 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $67,024,831 | 2,745,794 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $62,924,009 | 1,965,761 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $23,725,583 | 719,175 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $27,723,269 | 592,251 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||